Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Dublin, April 30, 2025 (GLOBE NEWSWIRE) -- The "RAGE Inhibitor - Pipeline Insight, 2025" has been added to ResearchAndMarkets.com's offering. The report is a comprehensive resource providing...
-
PharmAla releases Q2 financial statements showing increased customer deposits, shipments
-
2025 Letter to Shareholders
-
- NDA submitted for the treatment of central diabetes insipidus -- Expected 10-month review; commercial preparations underway for a potential Q1 2026 launch – DEER PARK, Ill., April 28, 2025 (GLOBE...
-
Austin, TX, USA, April 24, 2025 (GLOBE NEWSWIRE) -- Business Research Industry has published a new research report titled “Plastic Pallet Market Size, Trends and Insights By Material (High-Density...
-
CRANBURY, N.J., April 23, 2025 (GLOBE NEWSWIRE) -- Industry Sciences One (IS1), a division of MJH Life Sciences®, today announced the launch of IS1 Consulting, a custom consulting network designed...
-
SpotSee expands its condition monitoring portfolio with Telatemp acquisition.
-
Dublin, April 22, 2025 (GLOBE NEWSWIRE) -- The "Lipid-Based Pharma Excipients Market - Global Outlook & Forecast 2025-2030" report has been added to ResearchAndMarkets.com's offering.The...
-
Approval based on Phase 3 trials demonstrating Dupixent significantly reduced itch and hives compared to placebo In the U.S., there are more than 300,000 adults and adolescents aged 12 years and...
-
Dublin, April 18, 2025 (GLOBE NEWSWIRE) -- The "Competition Law for the Pharmaceutical Industry Training Course" training has been added to ResearchAndMarkets.com's offering. This comprehensive...